When was Synchron founded?

Synchron was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Where is Synchron located?

Synchron is headquartered in Brooklyn, United States. It is registered at Brooklyn, NY.

How many employees does Synchron have?

As of Jul 31, 2026, the latest employee count at Synchron is 133.

Is Synchron a funded company?

Synchron is a funded company, having raised a total of $345M across 6 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Apr 04, 2017.

When was the latest funding round of Synchron?

Synchron's latest funding was a $***** Series D round on Nov 06, 2025, with participation from 12 investors.

Where does Synchron rank among its competitors?

Synchron ranks 3rd amongst 67 active competitors, of which 25 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was BlueWind Medical, which secured $47.8M in May, 2026.

Who are the top competitors of Synchron?

Synchron's top competitors include ElectroCore, Neuralink and CorTec. Among them, BlueWind Medical secured the most recent funding round in May, 2026.

Synchron - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of implantable bioelectronics for the treatment of neurological conditions. The company offers a motor neuroprosthesis the Stentrode which helps paralyzed patients regain the ability to communicate. Also, provides endovascular neuromodulation minimally invasive device that stimulates brain or nerve activity for the treatment of Parkinson’s disease, epilepsy, depression, and others.

Website: synchron.com
Social
Email ID: *****@synchron.com, *****@synchron.com
Registered Address: Brooklyn, NY

Key Metrics

Founded Year

2016

Location

Brooklyn, United States

Stage

Series D

Total Funding

$345M in 6 rounds

Latest Funding Round

Series D, Nov 06, 2025, $*****

Investors

Khosla Ventures & 34 more

Ranked

3^rd among 67 active competitors

Employee Count

133 as on Jul 31, 2026

Investment & Acquisitions

ACQUANDAS

Similar Companies

ElectroCore & 69 more

View Synchron's full profile

Synchron is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
SYNCHRON, INC. CIN: 6770084 , United States, Active	Jun 23, 2022	-	-	-
Synchron, Inc CIN: 20-5231690 , United States, Active	Dec 31, 2015	-	53 (As on Dec 31, 2020)	-

Synchron has raised a total funding of $345M over 6 rounds. Its first funding round was on Apr 04, 2017. Its latest funding round was a Series D round on Nov 06, 2025 for $*****. 12 investors participated in its latest round. Synchron has 33 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of Synchron:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 06, 2025	9119534	Series D	1438067	4343179	8682806	4544033
Dec 15, 2022	2988217	Series C	8872718	5304881	8472510	Bezos Expeditions & 13 more
Dec 26, 2021	4008196	Grant (prize money)	4155518	2424653	7873085	Future Fund

Access funding benchmarks and valuations. Sign up today!

View details of Synchron's funding rounds and investors

The founders of Synchron is Rahul Sharma.

Here are the details of Synchron's key team members:

Rahul Sharma: Co-Founder of Synchron.

View details of Synchron's Founder profiles and Board Members

Synchron's employee count trend

Synchron has 133 employees as of Jul 26. Here is Synchron's employee count trend over the years:

Uncover Synchron's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Synchron include ElectroCore, Neuralink and CorTec. Here is the list of Top 10 competitors of Synchron, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	ElectroCore 2005, Basking Ridge (United States), Public	Developer of non-invasive vagus nerve stimulation devices	$161M	Core Ventures Group, Merck Global Health Innovation Fund ... & 6 others	70/100
2nd	Neuralink 2016, Fremont (United States), Series E	Provider of implantable brain-computer interfaces	$1.29B	Founders Fund, Vy Capital & 37 others	66/100
3rd	Synchron 2016, Brooklyn (United States), Series D	Developer of implantable bioelectronics for the treatment of neurological conditions	$345M	Qatar Investment Authority, Green Sands Equity ... & 33 others	62/100
4th	CorTec 2010, Freiburg im Breisgau (Germany), Series C	Manufacturer of active implantable neurotechnology devices, components, and sub-assemblies	$21.6M	Santo Venture Capital, K & SW Consult & 7 others	62/100
5th	ONWARD 2014, Eindhoven (Netherlands), Public	Developer of a therapeutic device for spinal cord injuries	$35M	Invest-NL, Olympic Investment & 17 others	61/100
6th	Nalu Medical 2014, Carlsbad (United States), Acquired	Developer of a neurostimulation system for managing intractable chronic pain	$231M	Gilde Healthcare, Novo Holdings & 9 others	61/100
7th	Paradromics 2015, Austin (United States), Series A	Provider of data streaming brain-computer interfaces	$88.7M	Prime Movers Lab, Synergy Ventures & 29 others	58/100
8th	Neurovalens 2013, Belfast (United Kingdom), Series A	Developer of non-invasive neurostimulation products	$26.1M	IQ Capital, ACF Investors & 57 others	57/100
9th	SpineX 2018, Los Angeles (United States), Seed	Developer of a medical device for neurological conditions	-	NIH, UCSF Rosenman Institute & 2 others	52/100
10th	BlueWind Medical 2010, Herzliya (Israel), Series B	Developer of neurostimulation device for the treatment of overactive bladder	$112M	ConvaTec, Rainbow Medical	49/100